-
Treatment of TGA patients with antiplatelet treatment is likely warranted, particularly if there are underlying vascular risk factors.
-
These papers and the accompanying editorial by Rascol bring attention to a known but under-recognized complication of ergot derivatives.
-
This is the latest of several important publications by Dr. Fullerton and her colleagues, at The University of California at San Francisco, describing details of the epidemiology of pediatric stroke during the last 2 decades of the 20th century.
-
-
FDA Rejects Plan B Bid; Rosuvastatin: Markets Most Potent Statin; FDA Actions
-
The interaction of cell to cell negative with cell to cell positive may be the crucial consideration between real patients.
-
The case for this PCR assay for aspergillus DNA remains unproven; and that proof can only be obtained by undertaking a formal prospective study in which samples for the detection of galactomannan and fungal DNA by PCR are taken at several predetermined intervals eg, 2-3 times weekly from all patients at risk.
-
A fourth pathogen, Rickettsia parkeri, has been identified as a newly identified cause of rickettsial spotted fever in the United States.
-
-
Mystery Lung Nodule in BakerCase Closed; Frequency of CJD in Asymptomatic Britons; Prepared Infant Formula a Risk; Does Mefloquine Pose an Unacceptable Risk to US Soldiers?; Adherence with HIV Vaccination Guidelines Poor
